A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients

被引：0
|
作者：
Walead Ebrahimizadeh
Karl-Philippe Guérard
Shaghayegh Rouzbeh
Eleonora Scarlata
Fadi Brimo
Palak G. Patel
Tamara Jamaspishvili
Lucie Hamel
Armen G. Aprikian
Anna Y. Lee
David M. Berman
John M. S. Bartlett
Simone Chevalier
Jacques Lapointe
机构：
[1] McGill University and the Research Institute of the McGill University Health Centre (RI MUHC),Department of Surgery, Division of Urology
[2] McGill University and the Research Institute of the McGill University Health Centre (RI MUHC),Department of Pathology
[3] Queen’s University,Department of Pathology & Molecular Medicine
[4] SUNY Upstate Medical University,Department of Pathology & Laboratory Medicine
[5] Ontario Institute for Cancer Research,Laboratory Medicine & Pathobiology
[6] University of Toronto,Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer
[7] The University of Edinburgh,undefined
[8] Current affiliation: IMV Inc.,undefined
来源：
British Journal of Cancer | 2023年 / 128卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2165 / 2174
页数：9
相关论文
共 50 条
  • [31] Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients
    Ribeiro, Franclim R.
    Henrique, Rui
    Martins, Ana T.
    Jeronimo, Carmen
    Teixeira, Manuel R.
    EUROPEAN UROLOGY, 2007, 52 (01) : 116 - 125
  • [32] Copy number alteration signatures as biomarkers in cancer: a review
    Doran, Conor Giles
    Pennington, Stephen R.
    BIOMARKERS IN MEDICINE, 2022, 16 (05) : 371 - 386
  • [33] The repertoire of copy number alteration signatures in human cancer
    Tao, Ziyu
    Wang, Shixiang
    Wu, Chenxu
    Wu, Tao
    Zhao, Xiangyu
    Ning, Wei
    Wang, Guangshuai
    Wang, Jinyu
    Chen, Jing
    Diao, Kaixuan
    Chen, Fuxiang
    Liu, Xue-Song
    BRIEFINGS IN BIOINFORMATICS, 2023, 24 (02)
  • [34] Copy number alteration and genomic instability in breast cancer
    Taira, F.
    BREAST, 2015, 24 : S39 - S39
  • [35] Usefulness of circulating mitochondrial DNA copy number as a prognostic biomarker in metastatic patients
    Moreau, M.
    Nelo, V.
    Pata-Merci, N.
    Stourm, A.
    Saulnier, P.
    Rouleau, E.
    Lacroix, L.
    Vasseur, D.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1405 - S1405
  • [36] Role of mitochondrial DNA copy number alteration in non-small cell lung cancer
    Lin, Chen-Sung
    Yeh, Yi-Chen
    Pan, Siao-Cian
    Lu, Shih-Yu
    Chen, Yann-Jang
    Chueh, Wen-Yu
    Wei, Yau-Huei
    FORMOSAN JOURNAL OF SURGERY, 2020, 53 (05) : 165 - 176
  • [37] Precision medicine for prostate cancer—improved outcome prediction for low-intermediate risk disease using a six-gene copy number alteration classifier
    William Lautert-Dutra
    Rodolfo Borges dos Reis
    Jeremy A. Squire
    British Journal of Cancer, 2023, 128 : 2163 - 2164
  • [38] A copy number and expression based classifier for breast cancer tumors
    Rueda, Oscar M.
    Ali, Raza H.
    Curtis, Christina
    Chin, Suet-Feung
    Bruna, Alejandra
    Russell, Roslin
    Pereira, Bernard
    Aparicio, Samuel
    Caldas, Carlos
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [39] Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
    Hieronymus, Haley
    Murali, Rajmohan
    Tin, Amy
    Yadav, Kamlesh
    Abida, Wassim
    Moller, Henrik
    Berney, Daniel
    Scher, Howard
    Carver, Brett
    Scardino, Peter
    Schultz, Nikolaus
    Taylor, Barry
    Vickers, Andrew
    Cuzick, Jack
    Sawyers, Charles L.
    ELIFE, 2018, 7
  • [40] Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer
    Xia, Yun
    Huang, Chiang-Ching
    Dittmar, Rachel
    Du, Meijun
    Wang, Yuan
    Liu, Hongyan
    Shenoy, Niraj
    Wang, Liang
    Kohli, Manish
    ONCOTARGET, 2016, 7 (24) : 35818 - 35831
12345